Provided by Tiger Trade Technology Pte. Ltd.

Roundhill GLP-1 & Weight Loss ETF

29.93
-0.2559-0.85%
Post-market: 29.950.0121+0.04%19:30 EDT
Volume:9K
Turnover:279.68K
Market Cap:55.97M
PE:- -
High:30.22
Open:30.22
Low:29.84
Close:30.19
52wk High:37.15
52wk Low:27.34
Shares:1.87M
Float Shares:1.87M
Volume Ratio:0.84
T/O Rate:0.50%
Dividend:0.41
Dividend Rate:1.37%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

TIPRANKS
·
Sep 25

Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential

TIPRANKS
·
Sep 25

Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 25

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 25

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
Sep 24

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

TradingKey
·
Sep 24

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Reuters
·
Sep 24

Viking Therapeutics Shares Down 15% After Co Prices Upsized Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
Sep 24

Viking Therapeutics, - Offering Size Increased to $275 Mln Common Stock and $225 Mln Notes

THOMSON REUTERS
·
Sep 24

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Deep News
·
Sep 24

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
Sep 24

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 24

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

Stock News
·
Sep 24

NYSE Most Active Issues

Dow Jones
·
Sep 24

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

TIPRANKS
·
Sep 24